<?xml version="1.0" encoding="utf-8"?>
<Return xmlns="http://www.irs.gov/efile" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" returnVersion="2022v5.0">
  <ReturnHeader binaryAttachmentCnt="0">
    <ReturnTs>2023-07-31T15:00:43-04:00</ReturnTs>
    <TaxPeriodEndDt>2022-12-31</TaxPeriodEndDt>
    <PreparerFirmGrp>
      <PreparerFirmEIN>382706146</PreparerFirmEIN>
      <PreparerFirmName>
        <BusinessNameLine1Txt>YEO &amp; YEO PC</BusinessNameLine1Txt>
      </PreparerFirmName>
      <PreparerUSAddress>
        <AddressLine1Txt>1450 EISENHOWER PLACE</AddressLine1Txt>
        <CityNm>ANN ARBOR</CityNm>
        <StateAbbreviationCd>MI</StateAbbreviationCd>
        <ZIPCd>481083283</ZIPCd>
      </PreparerUSAddress>
    </PreparerFirmGrp>
    <ReturnTypeCd>990</ReturnTypeCd>
    <TaxPeriodBeginDt>2022-01-01</TaxPeriodBeginDt>
    <Filer>
      <EIN>471671769</EIN>
      <BusinessName>
        <BusinessNameLine1Txt>EVERSIGHT INTERNATIONAL</BusinessNameLine1Txt>
      </BusinessName>
      <BusinessNameControlTxt>EVER</BusinessNameControlTxt>
      <PhoneNum>8002477250</PhoneNum>
      <USAddress>
        <AddressLine1Txt>3985 RESEARCH PARK DRIVE</AddressLine1Txt>
        <CityNm>ANN ARBOR</CityNm>
        <StateAbbreviationCd>MI</StateAbbreviationCd>
        <ZIPCd>48108</ZIPCd>
      </USAddress>
    </Filer>
    <BusinessOfficerGrp>
      <PersonNm>COLLIN ROSS</PersonNm>
      <PersonTitleTxt>VICE PRESIDENT</PersonTitleTxt>
      <PhoneNum>8002477250</PhoneNum>
      <SignatureDt>2023-07-20</SignatureDt>
      <DiscussWithPaidPreparerInd>true</DiscussWithPaidPreparerInd>
    </BusinessOfficerGrp>
    <SigningOfficerGrp>
      <PersonFullName>
        <PersonFirstNm>COLLIN</PersonFirstNm>
        <PersonLastNm>ROSS</PersonLastNm>
      </PersonFullName>
      <SSN>999009999</SSN>
    </SigningOfficerGrp>
    <IRSResponsiblePrtyInfoCurrInd>false</IRSResponsiblePrtyInfoCurrInd>
    <PreparerPersonGrp>
      <PreparerPersonNm>BRIAN R DIXON</PreparerPersonNm>
      <PTIN>P01321580</PTIN>
      <PhoneNum>7347691331</PhoneNum>
      <PreparationDt>2023-07-20</PreparationDt>
    </PreparerPersonGrp>
    <TaxYr>2022</TaxYr>
    <BuildTS>2023-04-26 12:10:37Z</BuildTS>
  </ReturnHeader>
  <ReturnData documentCnt="7">
    <IRS990 documentId="RetDoc3" referenceDocumentId="RetDoc6 RetDoc1">
      <PrincipalOfficerNm>COLLIN ROSS</PrincipalOfficerNm>
      <USAddress>
        <AddressLine1Txt>3985 RESEARCH PARK DR</AddressLine1Txt>
        <CityNm>ANN ARBOR</CityNm>
        <StateAbbreviationCd>MI</StateAbbreviationCd>
        <ZIPCd>48108</ZIPCd>
      </USAddress>
      <GrossReceiptsAmt>3012879</GrossReceiptsAmt>
      <GroupReturnForAffiliatesInd>false</GroupReturnForAffiliatesInd>
      <Organization501c3Ind>X</Organization501c3Ind>
      <WebsiteAddressTxt>WWW.EVERSIGHTVISION.ORG</WebsiteAddressTxt>
      <TypeOfOrganizationCorpInd>X</TypeOfOrganizationCorpInd>
      <FormationYr>2013</FormationYr>
      <LegalDomicileStateCd>MI</LegalDomicileStateCd>
      <ActivityOrMissionDesc>PRESERVING AND RESTORING SIGHT ON A GLOBAL SCALE.</ActivityOrMissionDesc>
      <VotingMembersGoverningBodyCnt>9</VotingMembersGoverningBodyCnt>
      <VotingMembersIndependentCnt>9</VotingMembersIndependentCnt>
      <TotalEmployeeCnt>0</TotalEmployeeCnt>
      <TotalVolunteersCnt>9</TotalVolunteersCnt>
      <TotalGrossUBIAmt>0</TotalGrossUBIAmt>
      <PYContributionsGrantsAmt>32972</PYContributionsGrantsAmt>
      <CYContributionsGrantsAmt>0</CYContributionsGrantsAmt>
      <PYProgramServiceRevenueAmt>2716455</PYProgramServiceRevenueAmt>
      <CYProgramServiceRevenueAmt>3012356</CYProgramServiceRevenueAmt>
      <PYInvestmentIncomeAmt>515</PYInvestmentIncomeAmt>
      <CYInvestmentIncomeAmt>523</CYInvestmentIncomeAmt>
      <CYOtherRevenueAmt>0</CYOtherRevenueAmt>
      <PYTotalRevenueAmt>2749942</PYTotalRevenueAmt>
      <CYTotalRevenueAmt>3012879</CYTotalRevenueAmt>
      <CYGrantsAndSimilarPaidAmt>0</CYGrantsAndSimilarPaidAmt>
      <CYBenefitsPaidToMembersAmt>0</CYBenefitsPaidToMembersAmt>
      <CYSalariesCompEmpBnftPaidAmt>0</CYSalariesCompEmpBnftPaidAmt>
      <CYTotalProfFndrsngExpnsAmt>0</CYTotalProfFndrsngExpnsAmt>
      <CYTotalFundraisingExpenseAmt>0</CYTotalFundraisingExpenseAmt>
      <PYOtherExpensesAmt>2344716</PYOtherExpensesAmt>
      <CYOtherExpensesAmt>2689180</CYOtherExpensesAmt>
      <PYTotalExpensesAmt>2344716</PYTotalExpensesAmt>
      <CYTotalExpensesAmt>2689180</CYTotalExpensesAmt>
      <PYRevenuesLessExpensesAmt>405226</PYRevenuesLessExpensesAmt>
      <CYRevenuesLessExpensesAmt>323699</CYRevenuesLessExpensesAmt>
      <TotalAssetsBOYAmt>13604636</TotalAssetsBOYAmt>
      <TotalAssetsEOYAmt>14405543</TotalAssetsEOYAmt>
      <TotalLiabilitiesBOYAmt>13140987</TotalLiabilitiesBOYAmt>
      <TotalLiabilitiesEOYAmt>13864434</TotalLiabilitiesEOYAmt>
      <NetAssetsOrFundBalancesBOYAmt>463649</NetAssetsOrFundBalancesBOYAmt>
      <NetAssetsOrFundBalancesEOYAmt>541109</NetAssetsOrFundBalancesEOYAmt>
      <InfoInScheduleOPartIIIInd>X</InfoInScheduleOPartIIIInd>
      <MissionDesc>PRESERVING AND RESTORING SIGHT ON A GLOBAL SCALE.</MissionDesc>
      <SignificantNewProgramSrvcInd>false</SignificantNewProgramSrvcInd>
      <SignificantChangeInd>false</SignificantChangeInd>
      <ExpenseAmt>2559419</ExpenseAmt>
      <RevenueAmt>3012356</RevenueAmt>
      <Desc>SURGICAL TISSUE PROVISION IN 2022, SUPPLY CHAIN DISRUPTIONS AND LOGISTICAL DIFFICULTIES DID NOT STOP EVERSIGHT INTERNATIONAL FROM PROVIDING TISSUE OR WORKING WITH SURGEONS IN 26 COUNTRIES OUTSIDE THE UNITED STATES AND SOUTH KOREA TO PROVIDE 1,912 TISSUES FOR TRANSPLANTATION, MAKING POSSIBLE THE GIFT OF SIGHT FOR THOSE IN NEED. FROM OUR EYE BANK IN SOUTH KOREA, WE PROVIDED FOR A RECORD 801 SIGHT-RESTORING CORNEA TRANSPLANTS FOR KOREAN PATIENTS. EVERSIGHT INTERNATIONAL IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEA TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF EVERSIGHT INTERNATIONAL'S INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. THAT MEANS HUNDREDS OF MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT INTERNATIONAL ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. EVERSIGHT INTERNATIONAL EMPOWERS COMMUNITIES TO TAKE MEANINGFUL STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL.</Desc>
      <ProgSrvcAccomActy2Grp>
        <ExpenseAmt>36368</ExpenseAmt>
        <Desc>BUILDING SUSTAINABLE SOLUTIONS GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. AND 89 PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. EVERSIGHT INTERNATIONAL IS ONE OF THE FEW NONPROFIT EYE BANK NETWORKS WITH THE EXPERTISE, CULTURAL COMPETENCE AND PHILANTHROPIC SUPPORT TO HELP DEVELOPING COUNTRIES ESTABLISH THEIR OWN EYE BANKING INFRASTRUCTURE. WE PARTNER WITH LOCAL GOVERNMENTS AND MEDICAL PROFESSIONALS, WORKING TOGETHER TO MAKE SUSTAINABLE EYE BANKING, DONATION AND TRANSPLANTATION A REALITY WHERE THE NEED IS GREATEST IN THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. PAKISTAN IS ONE SUCH COUNTRY WHERE MILLIONS SUFFER FROM PREVENTABLE BLINDNESS. IN 2019, WE WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF- THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. SINCE THEN, DESPITE MANY CHALLENGES INCLUDING SEVERE NATURAL DISASTERS AND ECONOMIC DISLOCATION, OUR PARTNERS IN PAKISTAN HAVE CONTINUED TO ADVANCE THE CAUSE OF CORNEA DONATION. WITH THE ACTIVE ADVICE AND SUPPORT OF EVERSIGHT, OUR PARTNER ORGANIZATIONS HAVE REGISTERED THOUSANDS OF PROSPECTIVE CORNEA DONORS AND CONTINUED TO BUILD PUBLIC SUPPORT FOR LOCAL CORNEA DONATION AND TRANSPLANTATION. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. IN THE MEANTIME, EVERSIGHT PROVIDED 555 TISSUES FOR TRANSPLANT IN PAKISTAN IN 2022. IN DECEMBER 2022, EVERSIGHT AND THE DEPARTMENT OF HEALTH - ABU DHABI FORMALIZED A PARTNERSHIP TO ESTABLISH THE FIRST EYE AND TISSUE BANK IN THE UNITED ARAB EMIRATES (UAE). THIS INITIATIVE WILL PROVIDE A CRITICAL RESOURCE TO THE APPROXIMATELY ONE MILLION PEOPLE IN THE REGION WHO SUFFER FROM CORNEAL BLINDNESS, INCLUDING MORE THAN 12,000 PEOPLE IN THE UAE, AND IS DIRECTLY ALIGNED WITH EVERSIGHT'S GOALS OF CREATING AND RESTORING VISION HEALTH AROUND THE WORLD. THROUGH ROBUST PARTNERSHIPS LIKE THESE, EVERSIGHT INTERNATIONAL ESTABLISHES LOCAL DONATION PROGRAMS AND CONDUCTS TECHNICAL LABORATORY TRAINING SO TISSUE CAN BE RECOVERED, PROCESSED AND DISTRIBUTED SAFELY, GIVING THOUSANDS MORE PEOPLE ACCESS TO LIFE-CHANGING CORNEAL TRANSPLANTS EVERY YEAR. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. WHETHER IT'S DEVELOPING MEDICAL STANDARDS, CLINICAL STAFF TRAINING, POLICIES AND PROCEDURES OR FACILITY DESIGN, EVERSIGHT PROVIDES THE KNOW-HOW FOR ALL ASPECTS OF EYE BANKING'S BEST PRACTICES. THESE TRANSFORMATIONAL EFFORTS ALSO RESULT IN THE INCREASED AVAILABILITY OF HUMAN EYE TISSUE FOR RESEARCH AND EDUCATION PURPOSES.</Desc>
      </ProgSrvcAccomActy2Grp>
      <ProgSrvcAccomActyOtherGrp>
        <Desc>CLINICAL TRAINING &amp; EDUCATION IN MANY PARTS OF THE WORLD, CORNEAL TRANSPLANTATION IS LIMITED BY A LACK OF FOUNDATIONAL AND ADVANCED CLINICAL TRAINING. EVERSIGHT IS A LEADING ORGANIZATION IN PROVIDING TRAINING TO CORNEA SPECIALIST PHYSICIANS AND HEALTHCARE PROFESSIONALS IN REGIONS MOST AFFECTED BY PREVENTABLE BLINDNESS. WE ARE WORKING WITH SOME OF THE LEADING CORNEAL SURGEONS IN THE WORLD TO SHARE SKILLS AND EXPERTISE WITH PHYSICIANS IN AFRICA, THE MIDDLE EAST, EAST ASIA AND ELSEWHERE, SO THEY CAN OFFER BETTER OPTIONS FOR PATIENTS AND SUPPORT THE DEVELOPMENT OF EYE BANKS IN THEIR HOME COUNTRIES. MORE THAN 200 SURGEONS AND OTHER CLINICIANS OUTSIDE THE UNITED STATES RECEIVED TRAINING THROUGH EVERSIGHT INTERNATIONAL IN 2022. WE HAVE INVESTED IN DEVELOPING ROBUST LIVE AND ON-DEMAND EDUCATION RESOURCES AVAILABLE FOR LITTLE-TO-NO COST, INCLUDING A COMPREHENSIVE SURGEON WEBINAR SERIES AND VIRTUAL WET LAB TRAINING CURRICULUM, PLUS EYE TISSUE AND BANKING EDUCATION AND MORE. EVERSIGHT'S CONTINUED, EFFECTIVE ADAPTATION TO ONLINE TRAINING AND EDUCATION IN 2022 RESULTED IN FAR GREATER ACCESSIBILITY TO SURGEONS WORLDWIDE. AND THE BUTTERFLY EFFECT OF THESE TRAININGS IS INCALCULABLE. EACH SURGICAL COORDINATOR WILL IMPACT MORE LIVES THROUGH THEIR IMPROVED KNOWLEDGE OF EYE BANKING AND TISSUE DISTRIBUTION. EACH EYE BANK TECHNICIAN CAN OFFER NEW TYPES OF PROCESSED TISSUES TO SURGEONS IN THEIR COMMUNITY. EACH SURGEON CAN PROVIDE BETTER PATIENT CARE FOR YEARS TO COME THROUGH ADVANCED TRANSPLANT TECHNIQUES. AND MANY MAY GO ON TO TRAIN THEIR PEERS, EXPONENTIALLY AMPLIFYING THE IMPACT.</Desc>
      </ProgSrvcAccomActyOtherGrp>
      <TotalProgramServiceExpensesAmt>2595787</TotalProgramServiceExpensesAmt>
      <DescribedInSection501c3Ind referenceDocumentId="RetDoc8">true</DescribedInSection501c3Ind>
      <ScheduleBRequiredInd>false</ScheduleBRequiredInd>
      <PoliticalCampaignActyInd>false</PoliticalCampaignActyInd>
      <LobbyingActivitiesInd>false</LobbyingActivitiesInd>
      <SubjectToProxyTaxInd>false</SubjectToProxyTaxInd>
      <DonorAdvisedFundInd referenceDocumentId="RetDoc4">false</DonorAdvisedFundInd>
      <ConservationEasementsInd referenceDocumentId="RetDoc4">false</ConservationEasementsInd>
      <CollectionsOfArtInd referenceDocumentId="RetDoc4">false</CollectionsOfArtInd>
      <CreditCounselingInd referenceDocumentId="RetDoc4">false</CreditCounselingInd>
      <DonorRstrOrQuasiEndowmentsInd referenceDocumentId="RetDoc4">false</DonorRstrOrQuasiEndowmentsInd>
      <ReportLandBuildingEquipmentInd referenceDocumentId="RetDoc4">true</ReportLandBuildingEquipmentInd>
      <ReportInvestmentsOtherSecInd referenceDocumentId="RetDoc4">false</ReportInvestmentsOtherSecInd>
      <ReportProgramRelatedInvstInd referenceDocumentId="RetDoc4">false</ReportProgramRelatedInvstInd>
      <ReportOtherAssetsInd referenceDocumentId="RetDoc4">true</ReportOtherAssetsInd>
      <ReportOtherLiabilitiesInd referenceDocumentId="RetDoc4">true</ReportOtherLiabilitiesInd>
      <IncludeFIN48FootnoteInd referenceDocumentId="RetDoc4">false</IncludeFIN48FootnoteInd>
      <IndependentAuditFinclStmtInd referenceDocumentId="RetDoc4">false</IndependentAuditFinclStmtInd>
      <ConsolidatedAuditFinclStmtInd referenceDocumentId="RetDoc4">true</ConsolidatedAuditFinclStmtInd>
      <SchoolOperatingInd>false</SchoolOperatingInd>
      <ForeignOfficeInd>false</ForeignOfficeInd>
      <ForeignActivitiesInd referenceDocumentId="RetDoc9">true</ForeignActivitiesInd>
      <MoreThan5000KToOrgInd referenceDocumentId="RetDoc9">false</MoreThan5000KToOrgInd>
      <MoreThan5000KToIndividualsInd referenceDocumentId="RetDoc9">false</MoreThan5000KToIndividualsInd>
      <ProfessionalFundraisingInd>false</ProfessionalFundraisingInd>
      <FundraisingActivitiesInd>false</FundraisingActivitiesInd>
      <GamingActivitiesInd>false</GamingActivitiesInd>
      <OperateHospitalInd>false</OperateHospitalInd>
      <GrantsToOrganizationsInd>false</GrantsToOrganizationsInd>
      <GrantsToIndividualsInd>false</GrantsToIndividualsInd>
      <ScheduleJRequiredInd referenceDocumentId="RetDoc5">true</ScheduleJRequiredInd>
      <TaxExemptBondsInd>false</TaxExemptBondsInd>
      <EngagedInExcessBenefitTransInd>false</EngagedInExcessBenefitTransInd>
      <PYExcessBenefitTransInd>false</PYExcessBenefitTransInd>
      <LoanOutstandingInd>false</LoanOutstandingInd>
      <GrantToRelatedPersonInd>false</GrantToRelatedPersonInd>
      <BusinessRlnWithOrgMemInd>false</BusinessRlnWithOrgMemInd>
      <BusinessRlnWithFamMemInd>false</BusinessRlnWithFamMemInd>
      <BusinessRlnWith35CtrlEntInd>false</BusinessRlnWith35CtrlEntInd>
      <DeductibleNonCashContriInd>false</DeductibleNonCashContriInd>
      <DeductibleArtContributionInd>false</DeductibleArtContributionInd>
      <TerminateOperationsInd>false</TerminateOperationsInd>
      <PartialLiquidationInd>false</PartialLiquidationInd>
      <DisregardedEntityInd referenceDocumentId="RetDoc7">false</DisregardedEntityInd>
      <RelatedEntityInd referenceDocumentId="RetDoc7">true</RelatedEntityInd>
      <RelatedOrganizationCtrlEntInd>true</RelatedOrganizationCtrlEntInd>
      <TransactionWithControlEntInd referenceDocumentId="RetDoc7">false</TransactionWithControlEntInd>
      <TrnsfrExmptNonChrtblRltdOrgInd referenceDocumentId="RetDoc7">false</TrnsfrExmptNonChrtblRltdOrgInd>
      <ActivitiesConductedPrtshpInd referenceDocumentId="RetDoc7">false</ActivitiesConductedPrtshpInd>
      <ScheduleORequiredInd>true</ScheduleORequiredInd>
      <IRPDocumentCnt>0</IRPDocumentCnt>
      <IRPDocumentW2GCnt>0</IRPDocumentW2GCnt>
      <BackupWthldComplianceInd>false</BackupWthldComplianceInd>
      <EmployeeCnt>0</EmployeeCnt>
      <UnrelatedBusIncmOverLimitInd>false</UnrelatedBusIncmOverLimitInd>
      <ForeignFinancialAccountInd>true</ForeignFinancialAccountInd>
      <ForeignCountryCd>KS</ForeignCountryCd>
      <ProhibitedTaxShelterTransInd>false</ProhibitedTaxShelterTransInd>
      <TaxablePartyNotificationInd>false</TaxablePartyNotificationInd>
      <NondeductibleContributionsInd>false</NondeductibleContributionsInd>
      <QuidProQuoContributionsInd>false</QuidProQuoContributionsInd>
      <Form8282PropertyDisposedOfInd>false</Form8282PropertyDisposedOfInd>
      <RcvFndsToPayPrsnlBnftCntrctInd>false</RcvFndsToPayPrsnlBnftCntrctInd>
      <PayPremiumsPrsnlBnftCntrctInd>false</PayPremiumsPrsnlBnftCntrctInd>
      <Form8899Filedind>false</Form8899Filedind>
      <Form1098CFiledInd>false</Form1098CFiledInd>
      <IndoorTanningServicesInd>false</IndoorTanningServicesInd>
      <SubjToTaxRmnrtnExPrchtPymtInd>false</SubjToTaxRmnrtnExPrchtPymtInd>
      <SubjectToExcsTaxNetInvstIncInd>false</SubjectToExcsTaxNetInvstIncInd>
      <InfoInScheduleOPartVIInd>X</InfoInScheduleOPartVIInd>
      <GoverningBodyVotingMembersCnt>9</GoverningBodyVotingMembersCnt>
      <IndependentVotingMemberCnt>9</IndependentVotingMemberCnt>
      <FamilyOrBusinessRlnInd>false</FamilyOrBusinessRlnInd>
      <DelegationOfMgmtDutiesInd>true</DelegationOfMgmtDutiesInd>
      <ChangeToOrgDocumentsInd>false</ChangeToOrgDocumentsInd>
      <MaterialDiversionOrMisuseInd>false</MaterialDiversionOrMisuseInd>
      <MembersOrStockholdersInd>false</MembersOrStockholdersInd>
      <ElectionOfBoardMembersInd>false</ElectionOfBoardMembersInd>
      <DecisionsSubjectToApprovaInd>false</DecisionsSubjectToApprovaInd>
      <MinutesOfGoverningBodyInd>true</MinutesOfGoverningBodyInd>
      <MinutesOfCommitteesInd>true</MinutesOfCommitteesInd>
      <OfficerMailingAddressInd>false</OfficerMailingAddressInd>
      <LocalChaptersInd>false</LocalChaptersInd>
      <Form990ProvidedToGvrnBodyInd>true</Form990ProvidedToGvrnBodyInd>
      <ConflictOfInterestPolicyInd>true</ConflictOfInterestPolicyInd>
      <AnnualDisclosureCoveredPrsnInd>true</AnnualDisclosureCoveredPrsnInd>
      <RegularMonitoringEnfrcInd>true</RegularMonitoringEnfrcInd>
      <WhistleblowerPolicyInd>true</WhistleblowerPolicyInd>
      <DocumentRetentionPolicyInd>true</DocumentRetentionPolicyInd>
      <CompensationProcessCEOInd>true</CompensationProcessCEOInd>
      <CompensationProcessOtherInd>false</CompensationProcessOtherInd>
      <InvestmentInJointVentureInd>false</InvestmentInJointVentureInd>
      <StatesWhereCopyOfReturnIsFldCd>MI</StatesWhereCopyOfReturnIsFldCd>
      <UponRequestInd>X</UponRequestInd>
      <BooksInCareOfDetail>
        <PersonNm>JULIE COLLINS</PersonNm>
        <PhoneNum>7347802100</PhoneNum>
        <USAddress>
          <AddressLine1Txt>3985 RESEARCH PARK DRIVE</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48108</ZIPCd>
        </USAddress>
      </BooksInCareOfDetail>
      <InfoInScheduleOPartVIIInd>X</InfoInScheduleOPartVIIInd>
      <Form990PartVIISectionAGrp>
        <PersonNm>MAHMOUD N GHAZZI MD PHD</PersonNm>
        <TitleTxt>CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>SAID ISSA MD</PersonNm>
        <TitleTxt>VICE CHAIR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>BUSHARAT AHMAD MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RASHID L BASHSHUR PHD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>DAVID CHU MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>HASAN FEHMI MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>AHMED F OMAR MD PHD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>MOHAMMAD ASHRAF QAZI FARHAT</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>RONY ROGER SAYEGH MD</PersonNm>
        <TitleTxt>DIRECTOR</TitleTxt>
        <AverageHoursPerWeekRt>1.00</AverageHoursPerWeekRt>
        <IndividualTrusteeOrDirectorInd>X</IndividualTrusteeOrDirectorInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>0</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>0</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>COLLIN ROSS</PersonNm>
        <TitleTxt>VICE PRESIDE</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>151204</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>46815</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <Form990PartVIISectionAGrp>
        <PersonNm>JULIE COLLINS</PersonNm>
        <TitleTxt>CFO</TitleTxt>
        <AverageHoursPerWeekRt>50.00</AverageHoursPerWeekRt>
        <OfficerInd>X</OfficerInd>
        <ReportableCompFromOrgAmt>0</ReportableCompFromOrgAmt>
        <ReportableCompFromRltdOrgAmt>208830</ReportableCompFromRltdOrgAmt>
        <OtherCompensationAmt>54373</OtherCompensationAmt>
      </Form990PartVIISectionAGrp>
      <TotReportableCompRltdOrgAmt>360034</TotReportableCompRltdOrgAmt>
      <TotalOtherCompensationAmt>101188</TotalOtherCompensationAmt>
      <FormerOfcrEmployeesListedInd>false</FormerOfcrEmployeesListedInd>
      <TotalCompGreaterThan150KInd>true</TotalCompGreaterThan150KInd>
      <CompensationFromOtherSrcsInd>false</CompensationFromOtherSrcsInd>
      <ProgramServiceRevenueGrp>
        <Desc>EYE TISSUE FEES</Desc>
        <BusinessCd>621990</BusinessCd>
        <TotalRevenueColumnAmt>3012356</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3012356</RelatedOrExemptFuncIncomeAmt>
      </ProgramServiceRevenueGrp>
      <TotalProgramServiceRevenueAmt>3012356</TotalProgramServiceRevenueAmt>
      <InvestmentIncomeGrp>
        <TotalRevenueColumnAmt>523</TotalRevenueColumnAmt>
        <ExclusionAmt>523</ExclusionAmt>
      </InvestmentIncomeGrp>
      <TotalRevenueGrp>
        <TotalRevenueColumnAmt>3012879</TotalRevenueColumnAmt>
        <RelatedOrExemptFuncIncomeAmt>3012356</RelatedOrExemptFuncIncomeAmt>
        <ExclusionAmt>523</ExclusionAmt>
      </TotalRevenueGrp>
      <InfoInScheduleOPartIXInd>X</InfoInScheduleOPartIXInd>
      <FeesForServicesOtherGrp>
        <TotalAmt>763036</TotalAmt>
        <ProgramServicesAmt>677577</ProgramServicesAmt>
        <ManagementAndGeneralAmt>85459</ManagementAndGeneralAmt>
      </FeesForServicesOtherGrp>
      <OfficeExpensesGrp>
        <TotalAmt>14536</TotalAmt>
        <ProgramServicesAmt>13954</ProgramServicesAmt>
        <ManagementAndGeneralAmt>582</ManagementAndGeneralAmt>
      </OfficeExpensesGrp>
      <OccupancyGrp>
        <TotalAmt>19673</TotalAmt>
        <ProgramServicesAmt>18886</ProgramServicesAmt>
        <ManagementAndGeneralAmt>787</ManagementAndGeneralAmt>
      </OccupancyGrp>
      <TravelGrp>
        <TotalAmt>36593</TotalAmt>
        <ProgramServicesAmt>33322</ProgramServicesAmt>
        <ManagementAndGeneralAmt>3271</ManagementAndGeneralAmt>
      </TravelGrp>
      <ConferencesMeetingsGrp>
        <TotalAmt>4774</TotalAmt>
        <ProgramServicesAmt>4347</ProgramServicesAmt>
        <ManagementAndGeneralAmt>427</ManagementAndGeneralAmt>
      </ConferencesMeetingsGrp>
      <InsuranceGrp>
        <TotalAmt>2518</TotalAmt>
        <ProgramServicesAmt>2417</ProgramServicesAmt>
        <ManagementAndGeneralAmt>101</ManagementAndGeneralAmt>
      </InsuranceGrp>
      <OtherExpensesGrp>
        <Desc>LAB &amp; TECH FEES</Desc>
        <TotalAmt>1550580</TotalAmt>
        <ProgramServicesAmt>1550580</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>CORPORATE TAXES</Desc>
        <TotalAmt>286646</TotalAmt>
        <ProgramServicesAmt>286646</ProgramServicesAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>BUSINESS DEVELOPMENT</Desc>
        <TotalAmt>8454</TotalAmt>
        <ProgramServicesAmt>8058</ProgramServicesAmt>
        <ManagementAndGeneralAmt>396</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <OtherExpensesGrp>
        <Desc>MISCELLANEOUS</Desc>
        <TotalAmt>2370</TotalAmt>
        <ManagementAndGeneralAmt>2370</ManagementAndGeneralAmt>
      </OtherExpensesGrp>
      <TotalFunctionalExpensesGrp>
        <TotalAmt>2689180</TotalAmt>
        <ProgramServicesAmt>2595787</ProgramServicesAmt>
        <ManagementAndGeneralAmt>93393</ManagementAndGeneralAmt>
        <FundraisingAmt>0</FundraisingAmt>
      </TotalFunctionalExpensesGrp>
      <CashNonInterestBearingGrp>
        <BOYAmt>660162</BOYAmt>
        <EOYAmt>857886</EOYAmt>
      </CashNonInterestBearingGrp>
      <AccountsReceivableGrp>
        <BOYAmt>390173</BOYAmt>
        <EOYAmt>421126</EOYAmt>
      </AccountsReceivableGrp>
      <PrepaidExpensesDefrdChargesGrp>
        <BOYAmt>833</BOYAmt>
        <EOYAmt>1250</EOYAmt>
      </PrepaidExpensesDefrdChargesGrp>
      <LandBldgEquipCostOrOtherBssAmt>11336</LandBldgEquipCostOrOtherBssAmt>
      <LandBldgEquipBasisNetGrp>
        <EOYAmt>11336</EOYAmt>
      </LandBldgEquipBasisNetGrp>
      <OtherAssetsTotalGrp>
        <BOYAmt>12553468</BOYAmt>
        <EOYAmt>13113945</EOYAmt>
      </OtherAssetsTotalGrp>
      <TotalAssetsGrp>
        <BOYAmt>13604636</BOYAmt>
        <EOYAmt>14405543</EOYAmt>
      </TotalAssetsGrp>
      <AccountsPayableAccrExpnssGrp>
        <BOYAmt>375876</BOYAmt>
        <EOYAmt>501699</EOYAmt>
      </AccountsPayableAccrExpnssGrp>
      <DeferredRevenueGrp>
        <BOYAmt>4465</BOYAmt>
        <EOYAmt>7372</EOYAmt>
      </DeferredRevenueGrp>
      <OtherLiabilitiesGrp>
        <BOYAmt>12760646</BOYAmt>
        <EOYAmt>13355363</EOYAmt>
      </OtherLiabilitiesGrp>
      <TotalLiabilitiesGrp>
        <BOYAmt>13140987</BOYAmt>
        <EOYAmt>13864434</EOYAmt>
      </TotalLiabilitiesGrp>
      <OrganizationFollowsFASB117Ind>X</OrganizationFollowsFASB117Ind>
      <NoDonorRestrictionNetAssetsGrp>
        <BOYAmt>443649</BOYAmt>
        <EOYAmt>541109</EOYAmt>
      </NoDonorRestrictionNetAssetsGrp>
      <DonorRestrictionNetAssetsGrp>
        <BOYAmt>20000</BOYAmt>
      </DonorRestrictionNetAssetsGrp>
      <TotalNetAssetsFundBalanceGrp>
        <BOYAmt>463649</BOYAmt>
        <EOYAmt>541109</EOYAmt>
      </TotalNetAssetsFundBalanceGrp>
      <TotLiabNetAssetsFundBalanceGrp>
        <BOYAmt>13604636</BOYAmt>
        <EOYAmt>14405543</EOYAmt>
      </TotLiabNetAssetsFundBalanceGrp>
      <InfoInScheduleOPartXIInd>X</InfoInScheduleOPartXIInd>
      <ReconcilationRevenueExpnssAmt>323699</ReconcilationRevenueExpnssAmt>
      <OtherChangesInNetAssetsAmt>-246239</OtherChangesInNetAssetsAmt>
      <MethodOfAccountingAccrualInd>X</MethodOfAccountingAccrualInd>
      <AccountantCompileOrReviewInd>false</AccountantCompileOrReviewInd>
      <FSAuditedInd>true</FSAuditedInd>
      <FSAuditedBasisGrp>
        <ConsolidatedBasisFinclStmtInd>X</ConsolidatedBasisFinclStmtInd>
      </FSAuditedBasisGrp>
      <AuditCommitteeInd>true</AuditCommitteeInd>
      <FederalGrantAuditRequiredInd>false</FederalGrantAuditRequiredInd>
    </IRS990>
    <IRS990ScheduleA documentId="RetDoc8">
      <PubliclySupportedOrg509a2Ind>X</PubliclySupportedOrg509a2Ind>
      <GiftsGrantsContrisRcvd509Grp>
        <CurrentTaxYearMinus3YearsAmt>4634</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>5756</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>32972</CurrentTaxYearMinus1YearAmt>
        <TotalAmt>43362</TotalAmt>
      </GiftsGrantsContrisRcvd509Grp>
      <GrossReceiptsAdmissionsGrp>
        <CurrentTaxYearMinus4YearsAmt>1375157</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1861013</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2033034</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2716455</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3012356</CurrentTaxYearAmt>
        <TotalAmt>10998015</TotalAmt>
      </GrossReceiptsAdmissionsGrp>
      <GrossReceiptsNonUnrltBusGrp>
        <CurrentTaxYearMinus4YearsAmt>18395</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>-3189</CurrentTaxYearMinus3YearsAmt>
        <TotalAmt>15206</TotalAmt>
      </GrossReceiptsNonUnrltBusGrp>
      <Total509Grp>
        <CurrentTaxYearMinus4YearsAmt>1393552</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1862458</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2038790</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2749427</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3012356</CurrentTaxYearAmt>
        <TotalAmt>11056583</TotalAmt>
      </Total509Grp>
      <AmountsRcvdDsqlfyPersonGrp>
        <CurrentTaxYearMinus2YearsAmt>1139</CurrentTaxYearMinus2YearsAmt>
        <TotalAmt>1139</TotalAmt>
      </AmountsRcvdDsqlfyPersonGrp>
      <SubstantialContributorsAmtGrp>
        <CurrentTaxYearMinus1YearAmt>1635703</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1811719</CurrentTaxYearAmt>
        <TotalAmt>3447422</TotalAmt>
      </SubstantialContributorsAmtGrp>
      <SubstAndDsqlfyPrsnsTotGrp>
        <CurrentTaxYearMinus2YearsAmt>1139</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>1635703</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>1811719</CurrentTaxYearAmt>
        <TotalAmt>3448561</TotalAmt>
      </SubstAndDsqlfyPrsnsTotGrp>
      <PublicSupportTotal509Amt>7608022</PublicSupportTotal509Amt>
      <GrossInvestmentIncome509Grp>
        <CurrentTaxYearMinus2YearsAmt>272</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>515</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>523</CurrentTaxYearAmt>
        <TotalAmt>1310</TotalAmt>
      </GrossInvestmentIncome509Grp>
      <InvestmentIncomeAndUBTIGrp>
        <CurrentTaxYearMinus2YearsAmt>272</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>515</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>523</CurrentTaxYearAmt>
        <TotalAmt>1310</TotalAmt>
      </InvestmentIncomeAndUBTIGrp>
      <TotalSupportCalendarYearGrp>
        <CurrentTaxYearMinus4YearsAmt>1393552</CurrentTaxYearMinus4YearsAmt>
        <CurrentTaxYearMinus3YearsAmt>1862458</CurrentTaxYearMinus3YearsAmt>
        <CurrentTaxYearMinus2YearsAmt>2039062</CurrentTaxYearMinus2YearsAmt>
        <CurrentTaxYearMinus1YearAmt>2749942</CurrentTaxYearMinus1YearAmt>
        <CurrentTaxYearAmt>3012879</CurrentTaxYearAmt>
        <TotalAmt>11057893</TotalAmt>
      </TotalSupportCalendarYearGrp>
      <PublicSupportCY509Pct>0.68800</PublicSupportCY509Pct>
      <PublicSupportPY509Pct>0.81110</PublicSupportPY509Pct>
      <InvestmentIncomeCYPct>0.00000</InvestmentIncomeCYPct>
      <InvestmentIncomePYPct>0.00000</InvestmentIncomePYPct>
      <ThirtyThrPctSuprtTestsCY509Ind>X</ThirtyThrPctSuprtTestsCY509Ind>
    </IRS990ScheduleA>
    <IRS990ScheduleD documentId="RetDoc4">
      <BuildingsGrp>
        <InvestmentCostOrOtherBasisAmt>11336</InvestmentCostOrOtherBasisAmt>
        <BookValueAmt>11336</BookValueAmt>
      </BuildingsGrp>
      <TotalBookValueLandBuildingsAmt>11336</TotalBookValueLandBuildingsAmt>
      <OtherAssetsOrgGrp>
        <Desc>INTERCOMPANY RECEIVABLE</Desc>
        <BookValueAmt>13093043</BookValueAmt>
      </OtherAssetsOrgGrp>
      <OtherAssetsOrgGrp>
        <Desc>DEPOSITS</Desc>
        <BookValueAmt>20902</BookValueAmt>
      </OtherAssetsOrgGrp>
      <TotalBookValueOtherAssetsAmt>13113945</TotalBookValueOtherAssetsAmt>
      <OtherLiabilitiesOrgGrp>
        <Desc>INTERCOMPANY PAYABLE</Desc>
        <Amt>13344027</Amt>
      </OtherLiabilitiesOrgGrp>
      <OtherLiabilitiesOrgGrp>
        <Desc>CAPITAL LEASE OBLIGATION</Desc>
        <Amt>11336</Amt>
      </OtherLiabilitiesOrgGrp>
      <TotalLiabilityAmt>13355363</TotalLiabilityAmt>
      <TotalRevEtcAuditedFinclStmtAmt>2766640</TotalRevEtcAuditedFinclStmtAmt>
      <OtherRevenueAmt>-246239</OtherRevenueAmt>
      <RevenueNotReportedAmt>-246239</RevenueNotReportedAmt>
      <RevenueSubtotalAmt>3012879</RevenueSubtotalAmt>
      <TotalRevenuePerForm990Amt>3012879</TotalRevenuePerForm990Amt>
      <TotExpnsEtcAuditedFinclStmtAmt>2689180</TotExpnsEtcAuditedFinclStmtAmt>
      <ExpensesSubtotalAmt>2689180</ExpensesSubtotalAmt>
      <TotalExpensesPerForm990Amt>2689180</TotalExpensesPerForm990Amt>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE D, PAGE 4, PART XI, LINE 2D</FormAndLineReferenceDesc>
        <ExplanationTxt>LOSS ON CURRENCY EXCHANGE -246,239</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleD>
    <IRS990ScheduleF documentId="RetDoc9">
      <GrantRecordsMaintainedInd>false</GrantRecordsMaintainedInd>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>CENTRAL AMERICA/CARIBBEAN</RegionTxt>
        <TypeOfActivitiesConductedTxt>PROGRAM SERVICES</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>TISSUE PROVIDED</SpecificServicesProvidedTxt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EAST ASIA/PACIFIC</RegionTxt>
        <TypeOfActivitiesConductedTxt>PROGRAM SERVICES</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>TISSUE PROVIDED</SpecificServicesProvidedTxt>
      </AccountActivitiesOutsideUSGrp>
      <AccountActivitiesOutsideUSGrp>
        <RegionTxt>EUROPE</RegionTxt>
        <TypeOfActivitiesConductedTxt>PROGRAM SERVICES</TypeOfActivitiesConductedTxt>
        <SpecificServicesProvidedTxt>TISSUE PROVIDED</SpecificServicesProvidedTxt>
      </AccountActivitiesOutsideUSGrp>
      <TransferToForeignCorpInd>false</TransferToForeignCorpInd>
      <InterestInForeignTrustInd>false</InterestInForeignTrustInd>
      <ForeignCorpOwnershipInd>true</ForeignCorpOwnershipInd>
      <PassiveForeignInvestmestCoInd>false</PassiveForeignInvestmestCoInd>
      <ForeignPartnershipInd>false</ForeignPartnershipInd>
      <BoycottCountriesInd>false</BoycottCountriesInd>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE F, PAGE 1, PART I, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>CENTRAL AMERICA/CARIBBEAN 0 0 EAST ASIA/PACIFIC 0 0 EUROPE 0 0</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleF>
    <IRS990ScheduleJ documentId="RetDoc5">
      <SeverancePaymentInd>false</SeverancePaymentInd>
      <SupplementalNonqualRtrPlanInd>false</SupplementalNonqualRtrPlanInd>
      <EquityBasedCompArrngmInd>false</EquityBasedCompArrngmInd>
      <CompBasedOnRevenueOfFlngOrgInd>false</CompBasedOnRevenueOfFlngOrgInd>
      <CompBsdOnRevRelatedOrgsInd>false</CompBsdOnRevRelatedOrgsInd>
      <CompBsdNetEarnsFlngOrgInd>false</CompBsdNetEarnsFlngOrgInd>
      <CompBsdNetEarnsRltdOrgsInd>false</CompBsdNetEarnsRltdOrgsInd>
      <AnyNonFixedPaymentsInd>false</AnyNonFixedPaymentsInd>
      <InitialContractExceptionInd>false</InitialContractExceptionInd>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>COLLIN ROSS</PersonNm>
        <TitleTxt>VICE PRESIDENT</TitleTxt>
        <CompensationBasedOnRltdOrgsAmt>151204</CompensationBasedOnRltdOrgsAmt>
        <DeferredCompRltdOrgsAmt>10101</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsRltdOrgsAmt>36714</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationRltdOrgsAmt>198019</TotalCompensationRltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <RltdOrgOfficerTrstKeyEmplGrp>
        <PersonNm>JULIE COLLINS</PersonNm>
        <TitleTxt>CFO</TitleTxt>
        <CompensationBasedOnRltdOrgsAmt>208830</CompensationBasedOnRltdOrgsAmt>
        <DeferredCompRltdOrgsAmt>13624</DeferredCompRltdOrgsAmt>
        <NontaxableBenefitsRltdOrgsAmt>40749</NontaxableBenefitsRltdOrgsAmt>
        <TotalCompensationRltdOrgsAmt>263203</TotalCompensationRltdOrgsAmt>
      </RltdOrgOfficerTrstKeyEmplGrp>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>SCHEDULE J, PART III</FormAndLineReferenceDesc>
        <ExplanationTxt>OFFICERS LISTED ON SCHEDULE J ARE PAID EMPLOYEES OF A RELATED ORGANIZATION, EVERSIGHT. SEE PART VII OF FORM 900 FOR ADDITIONAL DETAIL ON HOURS WORKED FOR THIS ENTITY AND RELATED ORGANIZATIONS.</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleJ>
    <IRS990ScheduleO documentId="RetDoc6">
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990</FormAndLineReferenceDesc>
        <ExplanationTxt>REPORTABLE COMPENSATION FROM RELATED ORGANIZATIONS IS COMPENSATION PAID TO EVERSIGHT UNDER AN EMPLOYEE LEASING ARRANGEMENT AND NOT DIRECT COMPENSATION TO AN OFFICER. ALL STAFF ARE PAID EMPLOYEES OF EVERSIGHT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4A</FormAndLineReferenceDesc>
        <ExplanationTxt>SURGICAL TISSUE PROVISION IN 2022, SUPPLY CHAIN DISRUPTIONS AND LOGISTICAL DIFFICULTIES DID NOT STOP EVERSIGHT INTERNATIONAL FROM PROVIDING TISSUE OR WORKING WITH SURGEONS IN 26 COUNTRIES OUTSIDE THE UNITED STATES AND SOUTH KOREA TO PROVIDE 1,912 TISSUES FOR TRANSPLANTATION, MAKING POSSIBLE THE GIFT OF SIGHT FOR THOSE IN NEED. FROM OUR EYE BANK IN SOUTH KOREA, WE PROVIDED FOR A RECORD 801 SIGHT-RESTORING CORNEA TRANSPLANTS FOR KOREAN PATIENTS. EVERSIGHT INTERNATIONAL IS FOCUSED ON MEETING THE HUMANITARIAN NEED FOR CORNEA TISSUES IN COUNTRIES WHERE SIGHT-RESTORING CORNEA TRANSPLANT PROCEDURES WOULD OTHERWISE BE COMPLETELY UNAVAILABLE. THE BENEFICIARIES OF EVERSIGHT INTERNATIONAL'S INITIATIVES INCLUDE THE HUNDREDS OF THOUSANDS OF PEOPLE WHO SUFFER FROM EYE INJURIES AND BLINDING EYE DISEASES THAT CAN BE TREATED THROUGH CORNEAL TRANSPLANTATION. BLINDING EYE DISEASES AFFECT HUNDREDS OF MILLIONS WORLDWIDE. THAT MEANS HUNDREDS OF MILLIONS OF PEOPLE CANNOT SEE THEIR LOVED ONES, LET ALONE WORK TO PROVIDE FOR THEIR FAMILIES. VISION LOSS RESULTS IN SUBSTANTIAL ECONOMIC IMPACT WORLDWIDE DUE TO THE INABILITY OF PEOPLE WHO ARE VISION IMPAIRED TO CONTRIBUTE IN THEIR COMMUNITIES. EVERSIGHT INTERNATIONAL ENVISIONS A WORLD WITHOUT BLINDNESS-A WORLD WHERE ALL PEOPLE IN EVERY COMMUNITY CAN LEAD INDEPENDENT, PRODUCTIVE LIVES THROUGH THE GIFT OF SIGHT. EVERSIGHT INTERNATIONAL EMPOWERS COMMUNITIES TO TAKE MEANINGFUL STEPS EVERY DAY TO MAKE VISION A REALITY FOR ALL.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>BUILDING SUSTAINABLE SOLUTIONS GLOBALLY, AN ESTIMATED 285 MILLION PEOPLE ARE VISUALLY IMPAIRED-MANY WITH TREATABLE CONDITIONS, BUT WITHOUT ACCESS TO CARE. AND 89 PERCENT OF VISION-IMPAIRED PEOPLE LIVE IN LOW- AND MIDDLE- INCOME COUNTRIES. EVERSIGHT INTERNATIONAL IS ONE OF THE FEW NONPROFIT EYE BANK NETWORKS WITH THE EXPERTISE, CULTURAL COMPETENCE AND PHILANTHROPIC SUPPORT TO HELP DEVELOPING COUNTRIES ESTABLISH THEIR OWN EYE BANKING INFRASTRUCTURE. WE PARTNER WITH LOCAL GOVERNMENTS AND MEDICAL PROFESSIONALS, WORKING TOGETHER TO MAKE SUSTAINABLE EYE BANKING, DONATION AND TRANSPLANTATION A REALITY WHERE THE NEED IS GREATEST IN THE MIDDLE EAST, PAKISTAN AND SOUTH KOREA. PAKISTAN IS ONE SUCH COUNTRY WHERE MILLIONS SUFFER FROM PREVENTABLE BLINDNESS. IN 2019, WE WORKED WITH PAKISTAN TO OPEN ITS FIRST STATE-OF- THE-ART EYE BANKS AS PART OF A NEW NATIONAL EYE BANKING NETWORK. SINCE THEN, DESPITE MANY CHALLENGES INCLUDING SEVERE NATURAL DISASTERS AND ECONOMIC DISLOCATION, OUR PARTNERS IN PAKISTAN HAVE CONTINUED TO ADVANCE THE CAUSE OF CORNEA DONATION. WITH THE ACTIVE ADVICE AND SUPPORT OF EVERSIGHT, OUR PARTNER ORGANIZATIONS HAVE REGISTERED THOUSANDS OF PROSPECTIVE CORNEA DONORS AND CONTINUED TO BUILD PUBLIC SUPPORT FOR LOCAL CORNEA DONATION AND TRANSPLANTATION. THE WORK CONTINUES-AND IT HAS GENERATED A NATIONAL MOVEMENT FOR ORGAN, TISSUE AND EYE DONOR REGISTRATION LED BY LOCAL PROFESSIONALS WHO TIRELESSLY EDUCATE AND ADVOCATE FOR THE GIFT OF SIGHT. IN THE MEANTIME, EVERSIGHT PROVIDED 555 TISSUES FOR TRANSPLANT IN PAKISTAN IN 2022. IN DECEMBER 2022, EVERSIGHT AND THE DEPARTMENT OF HEALTH - ABU DHABI FORMALIZED A PARTNERSHIP TO ESTABLISH THE FIRST EYE AND TISSUE BANK IN THE UNITED ARAB EMIRATES (UAE). THIS INITIATIVE WILL PROVIDE A CRITICAL RESOURCE TO THE APPROXIMATELY ONE MILLION PEOPLE IN THE REGION WHO SUFFER FROM CORNEAL BLINDNESS, INCLUDING MORE THAN 12,000 PEOPLE IN THE UAE, AND IS DIRECTLY ALIGNED WITH EVERSIGHT'S GOALS OF CREATING AND RESTORING VISION HEALTH AROUND THE WORLD. THROUGH ROBUST PARTNERSHIPS LIKE THESE, EVERSIGHT INTERNATIONAL ESTABLISHES LOCAL DONATION PROGRAMS AND CONDUCTS TECHNICAL LABORATORY TRAINING SO TISSUE CAN BE RECOVERED, PROCESSED AND DISTRIBUTED SAFELY, GIVING THOUSANDS MORE PEOPLE ACCESS TO LIFE-CHANGING CORNEAL TRANSPLANTS EVERY YEAR. ACCORDING TO THE WORLD HEALTH ORGANIZATION, EVERY DOLLAR SPENT ON IMPROVING EYE HEALTH IN UNDERDEVELOPED AREAS GENERATES A FOUR-FOLD RETURN ON INVESTMENT. WHETHER IT'S DEVELOPING MEDICAL STANDARDS, CLINICAL STAFF TRAINING, POLICIES AND PROCEDURES OR FACILITY DESIGN, EVERSIGHT PROVIDES THE KNOW-HOW FOR ALL ASPECTS OF EYE BANKING'S BEST PRACTICES. THESE TRANSFORMATIONAL EFFORTS ALSO RESULT IN THE INCREASED AVAILABILITY OF HUMAN EYE TISSUE FOR RESEARCH AND EDUCATION PURPOSES.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 2, PART III, LINE 4D</FormAndLineReferenceDesc>
        <ExplanationTxt>CLINICAL TRAINING &amp; EDUCATION IN MANY PARTS OF THE WORLD, CORNEAL TRANSPLANTATION IS LIMITED BY A LACK OF FOUNDATIONAL AND ADVANCED CLINICAL TRAINING. EVERSIGHT IS A LEADING ORGANIZATION IN PROVIDING TRAINING TO CORNEA SPECIALIST PHYSICIANS AND HEALTHCARE PROFESSIONALS IN REGIONS MOST AFFECTED BY PREVENTABLE BLINDNESS. WE ARE WORKING WITH SOME OF THE LEADING CORNEAL SURGEONS IN THE WORLD TO SHARE SKILLS AND EXPERTISE WITH PHYSICIANS IN AFRICA, THE MIDDLE EAST, EAST ASIA AND ELSEWHERE, SO THEY CAN OFFER BETTER OPTIONS FOR PATIENTS AND SUPPORT THE DEVELOPMENT OF EYE BANKS IN THEIR HOME COUNTRIES. MORE THAN 200 SURGEONS AND OTHER CLINICIANS OUTSIDE THE UNITED STATES RECEIVED TRAINING THROUGH EVERSIGHT INTERNATIONAL IN 2022. WE HAVE INVESTED IN DEVELOPING ROBUST LIVE AND ON-DEMAND EDUCATION RESOURCES AVAILABLE FOR LITTLE-TO-NO COST, INCLUDING A COMPREHENSIVE SURGEON WEBINAR SERIES AND VIRTUAL WET LAB TRAINING CURRICULUM, PLUS EYE TISSUE AND BANKING EDUCATION AND MORE. EVERSIGHT'S CONTINUED, EFFECTIVE ADAPTATION TO ONLINE TRAINING AND EDUCATION IN 2022 RESULTED IN FAR GREATER ACCESSIBILITY TO SURGEONS WORLDWIDE. AND THE BUTTERFLY EFFECT OF THESE TRAININGS IS INCALCULABLE. EACH SURGICAL COORDINATOR WILL IMPACT MORE LIVES THROUGH THEIR IMPROVED KNOWLEDGE OF EYE BANKING AND TISSUE DISTRIBUTION. EACH EYE BANK TECHNICIAN CAN OFFER NEW TYPES OF PROCESSED TISSUES TO SURGEONS IN THEIR COMMUNITY. EACH SURGEON CAN PROVIDE BETTER PATIENT CARE FOR YEARS TO COME THROUGH ADVANCED TRANSPLANT TECHNIQUES. AND MANY MAY GO ON TO TRAIN THEIR PEERS, EXPONENTIALLY AMPLIFYING THE IMPACT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART V, LINE 4B</FormAndLineReferenceDesc>
        <ExplanationTxt>KOREA (SOUTH)</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 3</FormAndLineReferenceDesc>
        <ExplanationTxt>EVERSIGHT INTERNATIONAL IS MANAGED BY EMPLOYEES OF EVERSIGHT.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 11B</FormAndLineReferenceDesc>
        <ExplanationTxt>990 IS REVIEWED BY THE CEO AND CFO PRIOR TO FILING. COMPLETED 990 IS PROVIDED VIA E-MAIL TO ALL BOARD MEMBERS FOR COMMENTS AND QUESTIONS PRIOR TO FILING.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 12C</FormAndLineReferenceDesc>
        <ExplanationTxt>THE POLICY IS REVIEWED DURING NEW EMPLOYEE ORIENTATION AND ANNUALLY WITH THE ENTIRE STAFF AND BOARD OF DIRECTORS. ANY POTENTIAL CONFLICTS OF INTEREST ARE REVIEWED BY SENIOR STAFF UPON DISCOVERY.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 15A</FormAndLineReferenceDesc>
        <ExplanationTxt>ALL STAFF ARE LEASED FROM EVERSIGHT, EVERSIGHT USES THE SAME PROCESS TO SET SALARIES FOR TOP OFFICIALS. A PERFORMANCE REVIEW IS CONDUCTED BY THE BOARD HR COMMITTEE; MERIT INCREASE IS RECOMMENDED BY THE HR COMMITTEE AND APPROVED BY THE BOARD. THE EXECUTIVE DIRECTOR IS NOT PART OF COMPENSATION DISCUSSION. THE EXECUTIVE DIRECTOR'S SALARY IS COMPARED TO SALARIES OF OTHER EXECUTIVE DIRECTOR'S AT PEER ORGANIZATIONS; OTHER EYE BANKS, OPOS, OTHER NONPROFIT ORGANIZATIONS OF SIMILAR SIZE.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PAGE 6, PART VI, LINE 19</FormAndLineReferenceDesc>
        <ExplanationTxt>GOVERNING DOCUMENTS, FINANCIAL STATEMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE UPON REQUEST.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART VII</FormAndLineReferenceDesc>
        <ExplanationTxt>COMPENSATION IS PAID BY A RELATED ENTITY, EVERSIGHT, AND IS REPORTED FOR THE W2 YEAR AND NOT THE TWELVE MONTHS ENDED DECEMBER 31, 2020.</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART IX, LINE 11G</FormAndLineReferenceDesc>
        <ExplanationTxt>OTHER PROFESSIONAL FEES 0 18,813 0 LEASED EMPLOYEES 479,557 66,646 0 OFFICER LEASED EMPLOYEE 198,020 0 0 TOTAL 677,577 85,459 0</ExplanationTxt>
      </SupplementalInformationDetail>
      <SupplementalInformationDetail>
        <FormAndLineReferenceDesc>FORM 990, PART XI, LINE 9</FormAndLineReferenceDesc>
        <ExplanationTxt>LOSS ON CURRENCY EXCHANGE -246,239</ExplanationTxt>
      </SupplementalInformationDetail>
    </IRS990ScheduleO>
    <IRS990ScheduleR documentId="RetDoc7">
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>3985 RESEARCH PARK DR</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48108</ZIPCd>
        </USAddress>
        <EIN>382117115</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MI</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>10</PublicCharityStatusTxt>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT NEW JERSEY</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>77 BRANT AVE SUITE 100</AddressLine1Txt>
          <CityNm>CLARK</CityNm>
          <StateAbbreviationCd>NJ</StateAbbreviationCd>
          <ZIPCd>07066</ZIPCd>
        </USAddress>
        <EIN>203345087</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>NJ</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT MICHIGAN</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>3985 RESEARCH PARK DR</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48108</ZIPCd>
        </USAddress>
        <EIN>273107692</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MI</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT ILLINOIS</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>547 WEST JACKSON BLVD SUITE 600</AddressLine1Txt>
          <CityNm>CHICAGO</CityNm>
          <StateAbbreviationCd>IL</StateAbbreviationCd>
          <ZIPCd>60661</ZIPCd>
        </USAddress>
        <EIN>273107617</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>IL</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>MIDWIRE SYSTEMS</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>3985 RESEARCH PARK DR</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48108</ZIPCd>
        </USAddress>
        <EIN>383557111</EIN>
        <PrimaryActivitiesTxt>SOFTWARE</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>MI</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>10</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT OHIO</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>6700 EUCLID AVE SUITE 101</AddressLine1Txt>
          <CityNm>CLEVELAND</CityNm>
          <StateAbbreviationCd>OH</StateAbbreviationCd>
          <ZIPCd>44106</ZIPCd>
        </USAddress>
        <EIN>455111431</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>OH</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedTaxExemptOrgGrp>
        <DisregardedEntityName>
          <BusinessNameLine1Txt>EVERSIGHT CONNECTICUT</BusinessNameLine1Txt>
        </DisregardedEntityName>
        <USAddress>
          <AddressLine1Txt>3985 RESEARCH PARK DR</AddressLine1Txt>
          <CityNm>ANN ARBOR</CityNm>
          <StateAbbreviationCd>MI</StateAbbreviationCd>
          <ZIPCd>48108</ZIPCd>
        </USAddress>
        <EIN>475113503</EIN>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileStateCd>CT</LegalDomicileStateCd>
        <ExemptCodeSectionTxt>3</ExemptCodeSectionTxt>
        <PublicCharityStatusTxt>7</PublicCharityStatusTxt>
        <DirectControllingEntityName>
          <BusinessNameLine1Txt>EVERSIGHT</BusinessNameLine1Txt>
          <BusinessNameLine2Txt>EVERSIGHT</BusinessNameLine2Txt>
        </DirectControllingEntityName>
        <ControlledOrganizationInd>false</ControlledOrganizationInd>
      </IdRelatedTaxExemptOrgGrp>
      <IdRelatedOrgTxblCorpTrGrp>
        <RelatedOrganizationName>
          <BusinessNameLine1Txt>EVERSIGHT KOREA LLC</BusinessNameLine1Txt>
        </RelatedOrganizationName>
        <ForeignAddress>
          <AddressLine1Txt>145 A 1638 TEHERAN-RO</AddressLine1Txt>
          <CityNm>GUMCHEONGU SEOUL</CityNm>
          <CountryCd>KS</CountryCd>
        </ForeignAddress>
        <PrimaryActivitiesTxt>EYE BANK</PrimaryActivitiesTxt>
        <LegalDomicileForeignCountryCd>KS</LegalDomicileForeignCountryCd>
        <DirectControllingNACd>N/A</DirectControllingNACd>
        <ControlledOrganizationInd>true</ControlledOrganizationInd>
      </IdRelatedOrgTxblCorpTrGrp>
      <ReceiptOfIntAnntsRntsRyltsInd>false</ReceiptOfIntAnntsRntsRyltsInd>
      <GiftGrntOrCapContriToOthOrgInd>false</GiftGrntOrCapContriToOthOrgInd>
      <GiftGrntCapContriFromOthOrgInd>false</GiftGrntCapContriFromOthOrgInd>
      <LoansOrGuaranteesToOtherOrgInd>false</LoansOrGuaranteesToOtherOrgInd>
      <LoansOrGuaranteesFromOthOrgInd>false</LoansOrGuaranteesFromOthOrgInd>
      <DivRelatedOrganizationInd>false</DivRelatedOrganizationInd>
      <AssetSaleToOtherOrgInd>false</AssetSaleToOtherOrgInd>
      <AssetPurchaseFromOtherOrgInd>false</AssetPurchaseFromOtherOrgInd>
      <AssetExchangeInd>false</AssetExchangeInd>
      <RentalOfFacilitiesToOthOrgInd>false</RentalOfFacilitiesToOthOrgInd>
      <RentalOfFcltsFromOthOrgInd>false</RentalOfFcltsFromOthOrgInd>
      <PerformOfServicesForOthOrgInd>false</PerformOfServicesForOthOrgInd>
      <PerformOfServicesByOtherOrgInd>true</PerformOfServicesByOtherOrgInd>
      <SharingOfFacilitiesInd>false</SharingOfFacilitiesInd>
      <PaidEmployeesSharingInd>true</PaidEmployeesSharingInd>
      <ReimbursementPaidToOtherOrgInd>false</ReimbursementPaidToOtherOrgInd>
      <ReimbursementPaidByOtherOrgInd>false</ReimbursementPaidByOtherOrgInd>
      <TransferToOtherOrgInd>false</TransferToOtherOrgInd>
      <TransferFromOtherOrgInd>false</TransferFromOtherOrgInd>
    </IRS990ScheduleR>
  </ReturnData>
</Return>
